ITGB1BP2 | Integrin beta 1 binding protein (melusin) 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LRRC49 | Leucine rich repeat containing 49 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
METTL11B | Methyltransferase like 11B | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MLIP | Muscular LMNA-interacting protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
MYLK3 | Myosin light chain kinase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
NEBL | Nebulette | Predicted intracellular proteins
| | | | | Tissue enhanced |
NES | Nestin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NEXN | Nexilin (F actin binding protein) | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
P2RX3 | Purinergic receptor P2X, ligand-gated ion channel, 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PALM2-AKAP2 | PALM2-AKAP2 readthrough | Predicted intracellular proteins
| | | | | Tissue enhanced |
PAQR9 | Progestin and adipoQ receptor family member IX | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PARK2 | Parkin RBR E3 ubiquitin protein ligase | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PDE1C | Phosphodiesterase 1C, calmodulin-dependent 70kDa | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PKP2 | Plakophilin 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PLA2G5 | Phospholipase A2, group V | Disease related genes Enzymes Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLCXD3 | Phosphatidylinositol-specific phospholipase C, X domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R14C | Protein phosphatase 1, regulatory (inhibitor) subunit 14C | Predicted intracellular proteins
| | | | | Tissue enhanced |
PRKAA2 | Protein kinase, AMP-activated, alpha 2 catalytic subunit | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PTPLA | Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
QRFPR | Pyroglutamylated RFamide peptide receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
RBM24 | RNA binding motif protein 24 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RBPMS2 | RNA binding protein with multiple splicing 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RCAN2 | Regulator of calcineurin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RNF103-CHMP3 | RNF103-CHMP3 readthrough | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF207 | Ring finger protein 207 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RP11-505K9.4 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000476300} | Predicted intracellular proteins
| | | | | Tissue enhanced |
RRAD | Ras-related associated with diabetes | Predicted intracellular proteins
| | | | | Tissue enhanced |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SCHIP1 | Schwannomin interacting protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC4A3 | Solute carrier family 4 (anion exchanger), member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SMYD1 | SET and MYND domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
SYNDIG1 | Synapse differentiation inducing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TLL2 | Tolloid-like 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
TMEM71 | Transmembrane protein 71 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TRIM55 | Tripartite motif containing 55 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
VWC2 | Von Willebrand factor C domain containing 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ZFP57 | ZFP57 zinc finger protein | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |